Xeris Pharmaceuticals | Bénéfice Avant Impôts



Pre Tax Profit Changement Date
Celltrion KRW 195.49B 78.5B 2025-03
Cspc Pharmaceutical CNY 944.38M 798.51M 2024-09
Dianthus Therapeutics USD -28440000 3.27M 2024-12
Divis Laboratories Ltd 7.26B 40M 2024-12
Eli Lilly USD 3.46B 2.08B 2025-03
Kangmei Pharma -5720000 15.38M 2024-09
Knight Therapeutics CAD -7144000 19.01M 2024-03
Laboratorios Farma 121.55M 84.42M 2024-12
Medical Developments International AUD -6390000 0 2023-12
Neuren Pharmaceuticals AUD 171.1M 159.25M 2024-12
Organigram Holdings CAD -22957000 4.15M 2024-12
Pacira USD 25.53M 24.05M 2024-12
Perrigo USD 151.3M 11.9M 2024-12
Pharma Mar EUR -3904000 13.45M 2025-03
Qiagen NV USD 169.1M 52.64M 2024-12
Sartorius EUR 99.5M 69.5M 2025-03
Supernus Pharmaceuticals USD 26.38M 45.36M 2024-12
Tilray USD -83239000 49.47M 2024-11
Zz Pientze Pharmaceu 1.18B 831.94M 2025-03



Xeris Pharmaceuticals Bénéfice Avant Impôts - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - May 2025.